About
Contact & Profiles
A5025686321
Research Areas
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Cancer Treatment and Pharmacology
- Breast Cancer Treatment Studies
- Meta-analysis and systematic reviews
- Healthcare Policy and Management
The University of Sydney
2024-2025
Abstract Introduction Many health economic evaluations rely on the validity of utility measurement for health-related quality life (HRQoL). While generic measures perform well in HRQoL assessments many diseases and patient populations, appropriateness cancer-specific disease burdens needs attention condition-specific could be a viable option. This study assessed clinical EORTC QLU-C10D, scoring algorithm QLQ-C30, patients with glioblastoma. We expect QLU-C10D to sensitive responsive...
10.1007/s10198-024-01729-4
article
EN
cc-by
The European Journal of Health Economics
2024-11-20
Coming Soon ...